Evidence map›Paper›PMID 26829186›Full record

ArticleFood & nutrition research2016

Supplementation with a fish protein hydrolysate (Micromesistius poutassou): effects on body weight, body composition, and CCK/GLP-1 secretion.

Vincenzo Nobile, Elisa Duclos, Angela Michelotti, Gioia Bizzaro, Massimo Negro, Florian Soisson

Open access · goldAbstract read
In one paragraph

Article in Food & nutrition research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. A Cell-Based Assessment of the Muscle Anabolic Potential of Blue Whiting (International journal of molecular sciences · 2023
    Article
  15. Processing Alaska Pollock Protein (Foods (Basel, Switzerland) · 2022
    Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 3 countries.

Vincenzo NobileFarcoderm Srl member of Complife Group, Pavia, Italy; vincenzo.nobile@farcoderm.com.
Elisa DuclosCompagnie des Pêches Saint-Malo Santé, Saint Malo, France.
Angela MichelottiFarcoderm Srl member of Complife Group, Pavia, Italy.
Gioia BizzaroFarcoderm Srl member of Complife Group, Pavia, Italy.
Massimo NegroLaboratory of Pharmacobiochemistry, Sports Nutrition and Nutriceuticals, University of Pavia, Pavia, Italy.
Florian SoissonCompagnie des Pêches Saint-Malo Santé, Saint Malo, France.
BirdLife International · KECentre Hospitalier de Saint-Malo · FRUniversity of Pavia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFish protein hydrolysates (FPHs) have been reported as a suitable source of proteins for human nutrition because of their balanced amino acid composition and positive effect on gastrointestinal absorption.

objectiveHere, we investigated the effect of a FPH, Slimpro(®), obtained from blue whiting (Micromesistius poutassou) muscle by enzymatic hydrolysis, on body composition and on stimulating cholecystokinin (CCK) and glucagon-like peptide-1 (GLP-1) secretion.

designA randomized clinical study was carried out on 120, slightly overweight (25 kg/m(2) ≤ BMI<30 kg/m(2)), male (25%) and female (75%) subjects. FPH was tested in a food supplement at two doses (1.4 and 2.8 g) to establish if a dose-effect relationship exists. Product use was associated with a mild hypocaloric diet (-300 kcal/day). Body composition (body weight; fat mass; extracellular water; and circumference of waist, thighs, and hips) and CCK/GLP-1 blood levels were measured at the beginning of the study and after 45 and 90 days of product use. CCK/GLP-1 levels were measured since they are involved in controlling food intake.

resultsTreated subjects reported an improvement of body weight composition and an increased blood concentration of both CCK and GLP-1. No differences were found between the 1.4 and 2.8 g FPH doses, indicating a plateau effect starting from 1.4 g FPH.

conclusionsBoth 1.4 and 2.8 g of FPH were effective in improving body composition and in increasing CCK and GLP-1 blood levels.

Indexed as

blue whitingbody compositionbody weightcholecystokininclinical studyfish protein hydrolysateglucagon-like peptide-1weight management

Identifiers

PMID26829186
PMCPMC4734037
OpenAlexW2259354634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.